Literature DB >> 11553999

Depression in Parkinson's disease. An update.

W H Oertel1, G U Höglinger, T Caraceni, F Girotti, T Eichhorn, A E Spottke, J C Krieg, W Poewe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553999

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  12 in total

1.  Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

Authors:  Susanne Steinlechner; Jessica Stahlberg; Birgit Völkel; Ana Djarmati; Johann Hagenah; Anja Hiller; Katja Hedrich; Inke König; Christine Klein; Rebekka Lencer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-03       Impact factor: 10.154

2.  Locomotor differences in mice expressing wild-type human α-synuclein.

Authors:  Genesys Giraldo; Mieu Brooks; Benoit I Giasson; Christopher Janus
Journal:  Neurobiol Aging       Date:  2018-02-06       Impact factor: 4.673

3.  Depression in Parkinson's disease.

Authors:  Barbara Jasinska-Myga; John D Putzke; Christian Wider; Zbigniew K Wszolek; Ryan J Uitti
Journal:  Can J Neurol Sci       Date:  2010-01       Impact factor: 2.104

Review 4.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 5.  Psychiatric symptoms in Parkinson's disease.

Authors:  Frank Schneider; Astrid Althaus; Volker Backes; Richard Dodel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

6.  Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.

Authors:  Katsuaki Suzuki; Kyoko Okada; Tomoyasu Wakuda; Chie Shinmura; Yosuke Kameno; Keiko Iwata; Taro Takahashi; Shiro Suda; Hideo Matsuzaki; Yasuhide Iwata; Kenji Hashimoto; Norio Mori
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

7.  Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease.

Authors:  Connie Veazey; Karon F Cook; Melinda Stanley; Eugene C Lai; Mark E Kunik
Journal:  J Clin Psychol Med Settings       Date:  2009-04-29

8.  Frequency of cognitive impairment and depression in Parkinson's disease: A preliminary case-control study.

Authors:  Oluwadamilola O Ojo; Njideka U Okubadejo; Frank I Ojini; Mustapha A Danesi
Journal:  Niger Med J       Date:  2012-04

9.  Noradrenaline and Parkinson's disease.

Authors:  Claire Delaville; Philippe De Deurwaerdère; Abdelhamid Benazzouz
Journal:  Front Syst Neurosci       Date:  2011-05-18

10.  Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.

Authors:  Anna Oczkowska; Jolanta Florczak-Wyspianska; Agnieszka Permoda-Osip; Michal Owecki; Margarita Lianeri; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2015-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.